Suppr超能文献

鉴定表达功能性程序性死亡受体-1 的新型脐血 NK 细胞亚群。

Identification of a novel cord blood NK cell subpopulation expressing functional programmed death receptor-1.

机构信息

Department of Experimental Medicine, University of Genoa, Genoa, Italy.

Department of Medicine (DAME), University of Udine, Udine, Italy.

出版信息

Front Immunol. 2023 Jun 22;14:1183215. doi: 10.3389/fimmu.2023.1183215. eCollection 2023.

Abstract

BACKGROUND

Natural Killer cells (NKs) represent the innate counterpart of TCRαβ lymphocytes and are characterized by a high anti-tumor and an anti-viral cytotoxic activity. Recently, it has been demonstrated that NKs can express PD-1 as an additional inhibitory receptor. Specifically, PD-1 was identified on a subpopulation of terminally differentiated NKs from healthy adults with previous HCMV infection. So far it is unknown whether PD-1 appears during NK-cell development and whether this process is directly or indirectly related to HCMV infection.

METHODS

In this study, we analyzed the expression and function of PD-1 on Cord Blood derived NKs (CB-NKs) on a large cohort of newborns through multiparametric cytofluorimetric analysis.

RESULTS

We identified PD-1 on CB-NKs in more than of half the newborns analyzed. PD-1 was present on CD56 NKs, and particularly abundant on CD56 NKs, but only rarely present on CD56 NKs. Importantly, unlike in adult healthy donors, in CB-NKs PD-1 is co-expressed not only with KIR, but also with NKG2A. PD-1 expression was independent of HCMV mother seropositivity and occurs in the absence of HCMV infection/reactivation during pregnancy. Notably, PD-1 expressed on CB-NKs was functional and mediated negative signals when triggered.

CONCLUSION

To our understanding, this study is the first to report PD-1 expression on CB derived NKs and its features in perinatal conditions. These data may prove important in selecting the most suitable CB derived NK cell population for the development of different immunotherapeutic treatments.

摘要

背景

自然杀伤细胞(NK 细胞)代表 TCRαβ 淋巴细胞的固有对应物,其特征是具有高抗肿瘤和抗病毒细胞毒性活性。最近,已经证明 NK 细胞可以表达 PD-1 作为另一种抑制性受体。具体而言,PD-1 被鉴定为先前感染过 HCMV 的健康成年人终末分化 NK 细胞的亚群上。到目前为止,尚不清楚 PD-1 是否出现在 NK 细胞发育过程中,以及这一过程是否与 HCMV 感染直接或间接相关。

方法

在这项研究中,我们通过多参数细胞荧光分析,在大量新生儿中分析了脐带血衍生 NK 细胞(CB-NK 细胞)上 PD-1 的表达和功能。

结果

我们在超过一半分析的新生儿中鉴定出 CB-NK 细胞上的 PD-1。PD-1 存在于 CD56 NK 细胞上,尤其是在 CD56 NK 细胞上丰富,但在 CD56 NK 细胞上很少存在。重要的是,与成年健康供体不同,在 CB-NK 细胞中,PD-1 不仅与 KIR 共表达,而且与 NKG2A 共表达。PD-1 的表达不依赖于 HCMV 母亲的血清阳性,并且发生在怀孕期间 HCMV 感染/再激活缺失的情况下。值得注意的是,CB-NK 细胞上表达的 PD-1 是功能性的,当被触发时会传递负信号。

结论

据我们所知,这项研究首次报道了 PD-1 在 CB 衍生 NK 细胞上的表达及其在围产期的特征。这些数据对于选择最适合用于开发不同免疫治疗方法的 CB 衍生 NK 细胞群体可能非常重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59e7/10335745/a5b0249b2b59/fimmu-14-1183215-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验